TY  - GEN
AU  - Maitland,M L
AU  - Wu,K
AU  - Sharma,M R
AU  - Jin,Y
AU  - Kang,S P
AU  - Stadler,W M
AU  - Karrison,T G
AU  - Ratain,M J
AU  - Bies,R R
TI  - Estimation of renal cell carcinoma treatment effects from disease progression modeling
SN  - 1532-6535
PY  - 2013///0517
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Clinical Trials, Phase II as Topic
KW  - statistics & numerical data
KW  - Clinical Trials, Phase III as Topic
KW  - Disease Progression
KW  - Kidney Neoplasms
KW  - Models, Statistical
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Phenylurea Compounds
KW  - Sorafenib
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Validation Study
UR  - https://doi.org/10.1038/clpt.2012.263
ER  -